Report Highlights
The global market for sleep aids is estimated to increase from $89.6 billion in 2022 to reach $125.3 billion by 2027, at a compound annual growth rate (CAGR) of 6.9% from 2022 through 2027.
Report Includes
- 33 data tables and 37 additional tables
- A comprehensive overview and an up-to-date analysis of the global market for sleep aids
- Analyses of the global market trends, with historic market revenue (sales figures) for 2021, estimates for 2022, forecasts for 2023 and 2025, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the upcoming market potential for sleep aids, and areas of focus to forecast this market into various segments and sub-segments
- Estimation of the actual market size and revenue forecast for global sleep aids market in USD million values, and corresponding market share analysis based on product type, sleep disorder type, and region
- Updated information on market drivers and opportunities for sleep aids industry, key shifts and regulations, technology specific challenges, and other demographic factors affecting the sleep aids market demand over the forecast period (2022-2027)
- Country specific data and market value analysis for the U.S., Canada, Germany, U.K., France, Italy, Spain, Australia, Japan, China, India, South Korea, and other emerging countries
- A comparative study and Porter’s Five Forces analysis considering both the micro and macro environmental factors prevailing in the sleep aids market
- Holistic review of the impact of the COVID-19 pandemic and the Russia-Ukraine war on the global market for sleep aids
- Coverage of the technological, economic, and business considerations of the sleep aids market, with global market data analyses and growth forecasts through 2027
- Identification of the major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, and segmental revenues
- Detailed company profiles of the leading market players, including Advanced Brain Monitoring Inc., Ambulatory Monitoring Inc. (AMI), Boehringer Ingelheim GmbH, Fisher & Paykel Healthcare Ltd., Pfizer Inc., and ResMed Inc.
Report Scope
This report offers a detailed picture of the sleep aids market.
This report highlights the current and future market potential for sleep aids and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2027, as well as key market players.
This report details market shares for sleep aids based on product, sleep disorder and geography. Based on product, the market is segmented into mattresses and pillows, sleep apnea devices, medications, sleep laboratories, and home sleep tests. Based on sleep disorder, the market is segmented into insomnia, sleep apnea, restless legs syndrome (RLS) and others.
By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2021 as the base year, with forecasts for 2021 through 2027. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||||
| Forecast period considered | 2022-2027 | ||||||||||||||||||||
| Base year market size | $84.6 billion | ||||||||||||||||||||
| Market size forecast | $125.3 billion | ||||||||||||||||||||
| Growth rate | CAGR of 6.9% for the forecast period of 2022-2027 | ||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||
| Segments covered | By Product, Sleep Disorder Type, and Region | ||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Latin America, and The Middle East and Africa (MEA) | ||||||||||||||||||||
| Countries covered | The U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, Australia, China, and India | ||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||
| Companies studied |
|
||||||||||||||||||||
Frequently Asked Questions (FAQs)
- Growing Aging Population
- Growing Number of Insomnia Disorders in the Young Population
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global market for sleep aids should grow from $81.2 billion in 2020 to $112.7 billion by 2025 with a compound annual growth rate (CAGR) of 6.8% for the period of 2020-2025.
Report Includes
- 25 data tables and 46 additional tables
- A comprehensive analysis of the global markets for sleep aids within the industry and its sub-segments
- Analyses of the global market trends, with data from 2018,2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Detailed insights into factors driving and restraining the growth of the global sleep aids market
- Estimation of the actual market size and revenue forecasts for sleep aids and related technologies, and corresponding market share analysis on the basis of type of product and sleep disorder with major regions and countries involved
- Impact of COVID-19 pandemic on the growth of global sleep aids market vs. the overall global economy
- Country specific data and analysis for the U.S., Canada, France, Germany, U.K., Spain, Italy, Japan, China, India, Australia, South Korea, and other emerging economies
- Competitive landscape featuring major market participants of the global sleep aids industry, and a Porter’s Five Forces analysis considering both the micro and macro environmental factors prevailing in the market
- Descriptive company profiles of the leading sleep aids industry players, including Apnea Sciences Corp., Boehringer Ingelheim International Gmbh, Cleveland Medical Devices Inc., Fisher & Paykel Healthcare Corp. Ltd., Pfizer Inc., and Resmed
Report Highlights
The global market for sleep aids and technologies is expected to reach $84.9 billion by 2021 from $66.3 billion in 2016, rising at a compound annual growth rate (CAGR) of 5.1% from 2016 through 2021.
Report Includes
- An overview of the global market for sleep aids and related technologies.
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021.
- Identification of the different disorders that manifest with sleep disorder symptoms.
- Information on different methods used to enhance sleep including medications, devices, and laboratories.
- Details on emerging technologies and developing trends.
- A look at the market's dynamics including growth drivers, restraints, and opportunities.
- Profiles of major players in the industry.
Report Highlights
The global market for sleep aids totaled $54.9 billion in 2013. This market is estimated to grow at a compound annual growth rate (CAGR) of 5.6% to reach $58.5 billion in 2014 and $76.7 billion by 2019.
Report Includes
- An overview of the global market for sleep aids and related technologies.
- Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
- Identification of the different disorders that manifest with sleep disorder symptoms.
- Information on different methods used to enhance sleep including medications, devices, and laboratories.
- Details on emerging technologies and developing trends.
Report Highlights
-
The worldwide sleep aids markets reached revenues of $25 billion in 2009. Revenues are anticipated to reach $33.2 billion in 2014, growing at a compound annual growth rate (CAGR) of 5.8% over the forecast period of 2009 to 2014.
-
The largest market in terms of annual revenues is the mattresses and pillows segment, but it is currently the slowest growing of all the markets. This segment was worth $10.6 billion in 2009 and is expected to reach $12.5 billion by 2015, a compound annual growth rate (CAGR) of 3.3%.
-
The second-largest market is sleep laboratories, with revenues of $6.7 billion in 2009. This segment is expected to grow at a compound annual growth rate (CAGR) of 6.5% to reach $9.2 billion in 2014.
Related Reports
Internet of Things (IoT) Sensors in Healthcare: Global Markets and Technologies
The global market for internet of things (IoT) sensors in healthcare is estimated to increase from $2.9 billion in 2023 to reach $8.6 billion by 2028, at a compound annual growth rate (CAGR) of 24.6% from 2023 through 2028.
AI in Remote Patient Monitoring: Global Market Outlook
This report provides a global market outlook of the AI in remote patient monitoring (RPM). It presents an up-to-date analysis of the global AI in RPM market, and data corresponding to market size, revenue forecast in USD million terms, and market share analysis based on the offering segments, technology, application, and region. The report examines new and emerging market trends and opportunities, and an assessment of the macroeconomic factors affecting the AI in remote patient monitoring market. The report concludes with the company profiles of leading market participants and their offerings in AI in remote patient monitoring market.
AI in Mental Health: Global Market Outlook
The report provides an overview of the global AI in mental health market and analyzes market trends. Using 2021 as the base year, the report provides estimated market data for the forecast period, 2022-2027. Revenue forecasts for this period are segmented based on organization size, component, provider, type, industry, and geography. It also highlights major trends and challenges that affect the market and the vendor landscape.
Wireless Medical Device Connectivity: Global Markets
The global market for wireless medical device connectivity is estimated to increase from $1.7 billion in 2022 to $5.0 billion by 2027, at a compound annual growth rate (CAGR) of 24.0% from 2022 through 2027.
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More